Search
    • Jan 24, 2021
    • 1 min read

ONO Receives a Manufacturing and Marketing Approval of Adlumiz® (Anamorelin), a Ghrelin Receptor Ago

"ONO Receives a Manufacturing and Marketing Approval of Adlumiz® (Anamorelin), a Ghrelin Receptor Agonist for the Treatment of Cancer Cachexia in Japan"





012221 ONO Receives a Manufacturing and
.
Download • 81KB